|
|
Hear from our CEO, Adrian Treverton, about treating non-melanoma skin cancer patients safely during COVID. Patients most likely to develop basal or squamous cell carcinoma are those in the age range at greater risk of serious illness from COVID, so safe and short...
Hear from Xstrahl's CEO, Adrian Treverton, on the future of skin cancer treatment. https://youtu.be/EOR9Y2eWwUw
Kilovoltage X-ray equipment maintains an integral role in the modern radiation therapy department for the treatment of non-melanoma skin cancer as well as other benign conditions and palliative applications. The use of low energy, therapeutic X-rays is often a...
Non-melanoma skin cancer is the most common cancer in the world today, with approximately 1.5 million cases in 2016—and that number is growing rapidly. While this type of cancer has a low morbidity rate, surgical treatment often leaves patients with dysfunctions,...
In this webcast, Dr. Richard Shaffer presents on a range of clinical conditions that can be treated with superficial-orthovoltage radiotherapy machines. The presentation primarily focuses on the treatment of non-melanoma skin cancer, including several illustrative...
In this webcast, the SmART Scientific Solutions team shares about and demonstrates SmART-XPS, the new treatment planning system for SARRP. https://www.youtube.com/embed/0RcLw8vtptM
Explore how radiotherapy can be used to treat keloid scarring in this presentation by Dr. Richard Shaffer. https://youtu.be/7lqpfIOQesQ
Today’s radiation research is complex and research interests are diverse. Using advanced translational radiation research systems, investigators can provide highly conformal radiation to preclinical models to study the full range of therapy techniques, including...
Musculoskeletal disorders affect a wide percentage of the population, causing significant pain and reducing functionality both in professional and leisure activities. Possible treatments for these debilitating conditions can be a significant and ongoing burden to the...